Literature DB >> 1736476

Management of voiding dysfunction with an implantable neuroprosthesis.

S W Siegel1.   

Abstract

We have been very encouraged by these preliminary results concerning the efficacy and safety of functional electrical neuromodulation in the management of chronic voiding complaints. There are a large number of patients within the standard practice of urology who are potential candidates for this form of management. The techniques of peripheral nerve evaluation and implantation are relatively simple to master and free of significant risks or complications. If the long-term results of the multicenter clinical trial parallel our preliminary results, this is a technique which should be embraced by urologists as a significant therapeutic advance in our field.

Entities:  

Mesh:

Year:  1992        PMID: 1736476

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  9 in total

1.  [Sacral neuromodulation in treatment of functional disorders of the lower urinary tract. An overview of basic principles, indications, outcomes].

Authors:  A Bannowsky; C Seif; S Sugimoto; G Böhler; C van der Horst; S Bross; P Alken; K-P Jünemann; P M Braun
Journal:  Urologe A       Date:  2003-04-04       Impact factor: 0.639

2.  Neuromodulation for the treatment of refractory interstitial cystitis.

Authors:  Kenneth M Peters
Journal:  Rev Urol       Date:  2002

3.  Sacral nerve stimulation for the management of voiding dysfunction.

Authors:  A K Das; M D White; P A Longhurst
Journal:  Rev Urol       Date:  2000

4.  Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy?

Authors:  Francesco Plotti; Marzio Angelo Zullo; Federica Guzzo; Roberto Montera; Roberto Angioli
Journal:  Support Care Cancer       Date:  2014-01-24       Impact factor: 3.603

5.  Sacral neuromodulation after stabilization of L2-S1 vertebrae with metallic fixation devices: is it feasible?

Authors:  Marzio Angelo Zullo; Roberto Montera; Francesco Plotti; Federica Guzzo; Roberto Angioli
Journal:  Int Urogynecol J       Date:  2010-10-30       Impact factor: 2.894

6.  Sacral nerve stimulation for faecal incontinence following a rectosigmoid resection for colorectal cancer.

Authors:  Michael E D Jarrett; Klaus E Matzel; Michael Stösser; John Christiansen; Harald Rosen; Michael A Kamm
Journal:  Int J Colorectal Dis       Date:  2005-04-21       Impact factor: 2.571

7.  A modified approach to patient's selection with improved clinical outcomes in sacral nerve modulation.

Authors:  Patrick Richard; Maude Carmel; Bechir Hage; Sophie Ramsay; Le Mai Tu
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

8.  Differences in sacral neuromodulation device infection rates based on preoperative antibiotic selection.

Authors:  Allen M Haraway; J Quentin Clemens; Chang He; Cynthia Stroup; Humphrey O Atiemo; Anne P Cameron
Journal:  Int Urogynecol J       Date:  2013-05-22       Impact factor: 2.894

9.  Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique.

Authors:  Kenneth M Peters; Jeffrey M Carey; David B Konstandt
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.